Tradewinds Capital Management’s Core Laboratories CLB Stock Holding History

Tradewinds Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-50	Closed	-$6K	–	654
2016 Q2	$6K	Buy	+50	New	+$6.04K	﹤0.01%	421
2015 Q4	–	Sell	-65	Closed	-$6K	–	642
2015 Q3	$6K	Buy	65 +20	+44%	+$2.17K	﹤0.01%	415
2015 Q2	$5K	Buy	+45	New	+$5.46K	﹤0.01%	474
2014 Q4	–	Sell	-150	Closed	-$22K	–	622
2014 Q3	$22K	Buy	150 +20	+15%	+$3.09K	0.02%	291
2014 Q2	$22K	Hold	130	–	–	0.02%	295
2014 Q1	$26K	Sell	130 -70	-35%	-$13.2K	0.02%	286
2013 Q4	$38K	Buy	+200	New	+$37.2K	0.03%	241

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

Tradewinds Capital Management's CLB Position: Q3 2016 in Review

Tradewinds Capital Management sold out of Core Laboratories (CLB) in Q3 2016, closing a stake of 50 shares — an estimated $6K sold.

Tradewinds Capital Management first reported a position in CLB in Q4 2013 and held it in 7 quarters. The position peaked at $38K in Q4 2013. 372 funds tracked by Wall St. Rank hold CLB as of Q3 2016.

Tradewinds Capital Management reported no remaining Core Laboratories position as of Q3 2016 after selling out during the quarter.
Tradewinds Capital Management sold 50 Core Laboratories shares in Q3 2016, an estimated $6K.
Tradewinds Capital Management first reported a position in Core Laboratories in Q4 2013 and held it in 7 quarters.
Tradewinds Capital Management's Core Laboratories position peaked at $38K in Q4 2013.
372 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2016.

Based on Tradewinds Capital Management's 13F filing for Q3 2016, filed 7 Nov 2016.